本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sionna Therapeutics

4.45
-0.2427-5.17%
成交量:20.38万
成交额:92.52万
市值:2.00亿
市盈率:-2.05
高:4.80
开:4.69
低:4.44
收:4.69
52周最高:54.97
52周最低:4.01
股本:4,499.81万
流通股本:1,672.55万
量比:0.86
换手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-2.1683
每股收益(LYR):-1.8835
净资产收益率:-32.34%
总资产收益率:-21.54%
市净率:0.75
市盈率(LYR):-2.36

数据加载中...

2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

重要事件披露

Form 8-K - Current report
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities